Patents by Inventor Hidemitsu Sato

Hidemitsu Sato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11281019
    Abstract: A lens driving device includes a base, a lens holder capable of holding a lens body, a movable support, a leaf spring that is disposed on the movable support and supports the lens holder such that the lens holder is movable along an optical axis of the lens body, a suspension wire that rises from the base along the optical axis and supports the movable support such that the movable support is movable in a direction intersecting the optical axis, and a drive mechanism that moves the movable support in the direction intersecting the optical axis. The leaf spring includes a spring body fixed to the movable support, a wire fixing part to which the suspension wire is fixed, and a first beam and a second beam that are disposed between the spring body and the wire fixing part and torsionally deformable.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: March 22, 2022
    Assignee: ALPS ALPINE CO., LTD.
    Inventors: Katsuhiko Otomo, Masayoshi Nakagawa, Hideaki Sato, Hidemitsu Sato
  • Publication number: 20190353921
    Abstract: A lens driving device includes a base, a lens holder capable of holding a lens body, a movable support, a leaf spring that is disposed on the movable support and supports the lens holder such that the lens holder is movable along an optical axis of the lens body, a suspension wire that rises from the base along the optical axis and supports the movable support such that the movable support is movable in a direction intersecting the optical axis, and a drive mechanism that moves the movable support in the direction intersecting the optical axis. The leaf spring includes a spring body fixed to the movable support, a wire fixing part to which the suspension wire is fixed, and a first beam and a second beam that are disposed between the spring body and the wire fixing part and torsionally deformable.
    Type: Application
    Filed: July 30, 2019
    Publication date: November 21, 2019
    Inventors: Katsuhiko OTOMO, Masayoshi NAKAGAWA, Hideaki SATO, Hidemitsu SATO
  • Publication number: 20100008940
    Abstract: The invention provides a peptide derived from the interleukin-13 receptor ?2, which serves as a HLA-A2-restricted cytotoxic T lymphocyte (CTL) epitope. The invention can be used as a vaccine for glioma and can be formulated into compositions for medical or veterinary use. In addition, the invention provides the use of a peptide derived from the Eph family of tyrosine kinase receptors which can be also used as a vaccine for glioma and can be formulated into compositions for medical or veterinary use.
    Type: Application
    Filed: September 17, 2009
    Publication date: January 14, 2010
    Applicant: University of Pittsburgh - Of the Commonweath System of Higher Education
    Inventors: Hideho Okada, Walter J. Storkus, Junichi Eguchi, Hidemitsu Sato
  • Patent number: 7612162
    Abstract: The invention provides a peptide derived from the interleukin-13 receptor ?2, which serves as a HLA-A2-restricted cytotoxic T lymphocyte (CTL) epitope. The invention can be used as a vaccine for glioma and can be formulated into compositions for medical or veterinary use. In addition, the invention provides the use of a peptide derived from the Eph family of tyrosine kinase receptors which can be also used as a vaccine for glioma and can be formulated into compositions for medical or veterinary use.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: November 3, 2009
    Assignee: University of Pittsburgh - Of the Commonwealth System of Higher Education
    Inventors: Hideho Okada, Walter J. Storkus, Junichi Eguchi, Hidemitsu Sato
  • Publication number: 20070167375
    Abstract: The invention provides a peptide derived from the interleukin-13 receptor ?2, which serves as a HLA-A2-restricted cytotoxic T lymphocyte (CTL) epitope. The invention can be used as a vaccine for glioma and can be formulated into compositions for medical or veterinary use. In addition, the invention provides the use of a peptide derived from the Eph family of tyrosine kinase receptors which can be also used as a vaccine for glioma and can be formulated into compositions for medical or veterinary use.
    Type: Application
    Filed: September 21, 2005
    Publication date: July 19, 2007
    Applicant: University of Pittsburgh of the Commonwealth System of Higher Education
    Inventors: Hideho Okada, Walter Storkus, Junichi Eguchi, Hidemitsu Sato